AF ablation

Head over to theHeart.org to read my review of the recently released RAAFT 2 trial–a randomized clinical trial of Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-Line Treatment of Symptomatic AF. The study adds significantly to the growing knowledge of how best to treat AF. JMM

{ 5 comments }

You all know how I feel about the value of education in the treatment and prevention of heart disease: It is self-evident and unquestionable. Along the lines of educating patients and docs, and in the spirit of February being Heart Health Awareness month, I believe The Heart Rhythm Society (HRS) deserves strong mention for their [...]

{ Comments on this entry are closed }

I am very excited. Nervous too. The ante has been upped. 240,000 members – 60,000 cardiologists – 38,000 other physicians – 66,000 Health care professionals. That’s the TheHeart.org: a website where one can find the latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world’s top cardiologists. It’s [...]

{ Comments on this entry are closed }

Let’s get off cell biology and back to something I really know. Atrial fibrillation, AF ablation and blood thinners. There was an important study published today in the Journal of the American College of Cardiology concerning the use of the new blood thinner, dabigatran (Pradaxa), around the time of AF ablation. A very concise overview, [...]

{ Comments on this entry are closed }

Whew. The Boston AF symposium digests slowly. Processing nearly the entirety of AF into just three days borders on ridiculous. Well at least for us regular guys, you know, those of us that doctor, not model things mathematically. This year, I tried something new: posting slightly refined quick notes on each lecture, mostly in real-time. [...]

{ Comments on this entry are closed }

Today is the third and final day of the Boston AF symposium. (My editorial comments in italics.) Dr Hugh Caulkins started the day by reviewing the major clinical trials of AF ablation. A lot of these I have written about previously. One of the most pivotal trials to mention is CABANA. Here, investigators are enrolling [...]

{ Comments on this entry are closed }